Determination of a novel angiotensin-AT 1 antagonist CR 3210 in biological samples by HPLC

Author： Rizzo M.   Anzini M.   Cappelli A.   Vomero S.   Ventrice D.   De Sarro G.   Procopio S.   Costa N.   Makovec F.  

Publisher： Elsevier

ISSN： 0014-827X

Source： Il Farmaco, Vol.58, Iss.9, 2003-09, pp. : 837-844

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valsartan: a novel angiotensin Type 1 receptor antagonist

By Thürmann P.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 337-350

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

By Shibasaki M.   Fujimori A.   Takanashi M.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

Development and Validation of a Highly Sensitive HPLC Method for Determination of Paclitaxel in Pharmaceutical Dosage forms and Biological Samples

By  

Current Pharmaceutical Analysis, Vol. 10, Iss. 3, 2014-08 ,pp. : 185-192

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Study for the Determination of Gemifloxacin by HPLC and Microbiological Methods from Pharmaceutical Preparations and Biological Samples

By  

Current Pharmaceutical Analysis, Vol. 11, Iss. 3, 2015-08 ,pp. : 193-200

Bentham Science Publishers

Access to resources Recommend Favorite

Renal pharmacology of GR138950, a novel non-peptide angiotensin AT 1 receptor antagonist

By Clark K.L.   Robertson M.J.   Drew G.M.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite